Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective

Mirre Scholte; Bram Ramaekers; Evangelos Danopoulos; Sabine E Grimm; Andrea Fernandez Coves; Xiaoyu Tian; Thomas Debray; Jiongyu Chen; Lisa Stirk; Rachel Croft; Manuela Joore; Nigel Armstrong

doi:10.1007/s40273-024-01394-8

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective

Mirre Scholte^*, Bram Ramaekers, Evangelos Danopoulos, Sabine E Grimm, Andrea Fernandez Coves, Xiaoyu Tian, Thomas Debray, Jiongyu Chen, Lisa Stirk, Rachel Croft, Manuela Joore, Nigel Armstrong

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	829-832
Number of pages	4
Journal	Pharmacoeconomics
Volume	42
Issue number	8
DOIs	https://doi.org/10.1007/s40273-024-01394-8
Publication status	Published - Aug 2024

Access to Document

10.1007/s40273-024-01394-8Licence: CC BY-NC

Cite this

Scholte, M., Ramaekers, B., Danopoulos, E., Grimm, S. E., Fernandez Coves, A., Tian, X., Debray, T., Chen, J., Stirk, L., Croft, R., Joore, M., & Armstrong, N. (2024). Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective. Pharmacoeconomics, 42(8), 829-832. https://doi.org/10.1007/s40273-024-01394-8

@article{3a2a027d1a7b439395424124695910fd,

title = "Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective",

author = "Mirre Scholte and Bram Ramaekers and Evangelos Danopoulos and Grimm, {Sabine E} and {Fernandez Coves}, Andrea and Xiaoyu Tian and Thomas Debray and Jiongyu Chen and Lisa Stirk and Rachel Croft and Manuela Joore and Nigel Armstrong",

year = "2024",

month = aug,

doi = "10.1007/s40273-024-01394-8",

language = "English",

volume = "42",

pages = "829--832",

journal = "Pharmacoeconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

number = "8",

}

Scholte, M, Ramaekers, B, Danopoulos, E, Grimm, SE , Fernandez Coves, A, Tian, X, Debray, T, Chen, J, Stirk, L, Croft, R, Joore, M & Armstrong, N 2024, 'Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective', Pharmacoeconomics, vol. 42, no. 8, pp. 829-832. https://doi.org/10.1007/s40273-024-01394-8

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective. / Scholte, Mirre; Ramaekers, Bram; Danopoulos, Evangelos et al.
In: Pharmacoeconomics, Vol. 42, No. 8, 08.2024, p. 829-832.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes

T2 - An External Assessment Group Perspective

AU - Scholte, Mirre

AU - Ramaekers, Bram

AU - Danopoulos, Evangelos

AU - Grimm, Sabine E

AU - Fernandez Coves, Andrea

AU - Tian, Xiaoyu

AU - Debray, Thomas

AU - Chen, Jiongyu

AU - Stirk, Lisa

AU - Croft, Rachel

AU - Joore, Manuela

AU - Armstrong, Nigel

PY - 2024/8

Y1 - 2024/8

U2 - 10.1007/s40273-024-01394-8

DO - 10.1007/s40273-024-01394-8

M3 - Article

SN - 1170-7690

VL - 42

SP - 829

EP - 832

JO - Pharmacoeconomics

JF - Pharmacoeconomics

IS - 8

ER -